Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure.

A. Ibarra Fernández (Ciudad de México, Mexico), D. González Islas (Ciudad de México, Mexico), A. Orea Tejeda (Ciudad de México, Mexico), F. Salgado Fernández (Ciudad de México, Mexico), A. Jiménez Valetín (Ciudad de México, Mexico), A. Flores Vargas (Ciudad de México, Mexico), R. Sánchez Santillán (Ciudad de México, Mexico), R. Davila Ramos (Ciudad de México, Mexico), K. Balderas Muñoz (Ciudad de México, Mexico), V. Peláez Hernández (Ciudad de México, Mexico)

Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Session: Cardiovascular comorbidities in COPD
Session type: Thematic Poster
Number: 2666
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ibarra Fernández (Ciudad de México, Mexico), D. González Islas (Ciudad de México, Mexico), A. Orea Tejeda (Ciudad de México, Mexico), F. Salgado Fernández (Ciudad de México, Mexico), A. Jiménez Valetín (Ciudad de México, Mexico), A. Flores Vargas (Ciudad de México, Mexico), R. Sánchez Santillán (Ciudad de México, Mexico), R. Davila Ramos (Ciudad de México, Mexico), K. Balderas Muñoz (Ciudad de México, Mexico), V. Peláez Hernández (Ciudad de México, Mexico). Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure.. 2666

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

Comparing the Comorbidity burden in Chronic Obstructive Pulmonary Disease and Heart Failure : evidence from a large population cohort
Source: International Congress 2019 – More and more COPD
Year: 2019

Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Influence of coexistent Chronic Obstructive Pulmonary Disease in Heart Failure on linear and nonlinear dynamics of Heart Rate Variability
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019


Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Nutritional Disorders of Patients with Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019

Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand?
Source: International Congress 2018 – COPD management
Year: 2018


Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020

Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020

Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD
Source: Eur Respir J 2014; 44: 1177-1187
Year: 2014



Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 2014
Year: 2014